Peri-tumoral Tertiary Lymphoid Structures Predict Good Prognosis in patients with Gastric Neuroendocrine Carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Bokyung | - |
dc.contributor.author | Hong, Seung-Mo | - |
dc.contributor.author | Hong, Soon Auck | - |
dc.contributor.author | Jun, Sun-Young | - |
dc.date.accessioned | 2024-01-09T15:01:08Z | - |
dc.date.available | 2024-01-09T15:01:08Z | - |
dc.date.issued | 2023-03 | - |
dc.identifier.issn | 0023-6837 | - |
dc.identifier.issn | 1530-0307 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/70566 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.title | Peri-tumoral Tertiary Lymphoid Structures Predict Good Prognosis in patients with Gastric Neuroendocrine Carcinoma | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | LABORATORY INVESTIGATION, v.103, no.3, pp S517 - S517 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000990969801044 | - |
dc.citation.endPage | S517 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | S517 | - |
dc.citation.title | LABORATORY INVESTIGATION | - |
dc.citation.volume | 103 | - |
dc.type.docType | Meeting Abstract | - |
dc.publisher.location | 미국 | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Pathology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Pathology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.